These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2148193)

  • 21. [Prazosin in the treatment of hypertension: effect on lipid metabolism].
    Hitzenberger G; Neumann K; Dietz S; Egger H; Hariri K; Kittler E; Niedrist W; Nitsch-Fritz R; Ravanelli O; Sapinsky H
    Wien Med Wochenschr; 1987 Nov; 137(22):525-30. PubMed ID: 3433787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 24-hour control of blood pressure by once daily doxazosin: a multicentre double-blind comparison with placebo.
    Smyth P; Pringle S; Jackson G; Lorimer AR
    Eur J Clin Pharmacol; 1988; 34(6):613-8. PubMed ID: 2971549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of alpha-blockers in the management of hypertension: a practical view.
    McInnes GT
    J Hum Hypertens; 1991 Aug; 5(4):313-6. PubMed ID: 1683406
    [No Abstract]   [Full Text] [Related]  

  • 24. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of doxazosin on vascular collagen synthesis, arterial pressure and serum lipids in the spontaneously hypertensive rat.
    Chichester CO; Rodgers RL
    J Cardiovasc Pharmacol; 1987; 10 Suppl 9():S21-6. PubMed ID: 2447437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension.
    Young RA; Brogden RN
    Drugs; 1988 May; 35(5):525-41. PubMed ID: 2899495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind and cross-over comparison of once daily doxazosin and placebo with steady-state pharmacokinetics in elderly hypertensive patients.
    Scott PJ; Hosie J; Scott MG
    Eur J Clin Pharmacol; 1988; 34(2):119-23. PubMed ID: 2968267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of doxazosin in the treatment of patients with mild or moderate essential hypertension and elevated levels of cholesterol.
    Taylor SH
    Am Heart J; 1991 Jan; 121(1 Pt 2):362-6. PubMed ID: 1824662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxazosin for treatment of hypertension.
    Med Lett Drugs Ther; 1991 Feb; 33(838):15-6. PubMed ID: 1825232
    [No Abstract]   [Full Text] [Related]  

  • 30. Doxazosin in patients with hypertension.
    Conrad KA; Fagan TC; Mackie MJ; Mayshar PV; Lee S; Souhrada JF; Falkner FC; Lazar JD
    Eur J Clin Pharmacol; 1988; 35(1):21-4. PubMed ID: 2975595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxazosin in the treatment of essential hypertension in general medical practice in Latin America.
    Silva H; Fonseca R; Marshall D
    Am Heart J; 1991 Jan; 121(1 Pt 2):329-35. PubMed ID: 1824656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension.
    Pool JL; Taylor AA; Nelson EB
    Am J Med; 1989 Aug; 87(2A):57S-61S. PubMed ID: 2569825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of doxazosin monotherapy on blood pressure and plasma lipids in patients with essential hypertension.
    Cubeddu LX; Pool JL; Bloomfield R; Klotman PE; Pickering BI; Wombolt DG; Nelson EB; Halperin A
    Am J Hypertens; 1988 Apr; 1(2):158-67. PubMed ID: 2969740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of doxazosin on serum lipids: a review of the clinical data and molecular basis for altered lipid metabolism.
    Pool JL
    Am Heart J; 1991 Jan; 121(1 Pt 2):251-9; discussion 259-60. PubMed ID: 1824647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost-benefit approach to pricing new medicines: doxazosin versus beta-blocker treatment in Sweden.
    Lindgren B
    Am Heart J; 1990 Mar; 119(3 Pt 2):748-53. PubMed ID: 1968701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary results of the Norwegian doxazosin postmarketing surveillance study: a twelve-week experience.
    Holme I; Fauchald P; Rugstad HE; Stokke HP
    Am Heart J; 1991 Jan; 121(1 Pt 2):260-7. PubMed ID: 1824648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxazosin effects on insulin and glucose in hypertensive patients. The Finnish Multicenter Study Group.
    Lehtonen A
    Am Heart J; 1991 Apr; 121(4 Pt 2):1307-11. PubMed ID: 1826187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of doxazosin in systemic hypertension.
    Ames RP; Chrysant SG; Gonzalez F; Schnaper HW; Spann S; Velasquez MT
    Am J Cardiol; 1989 Jul; 64(3):203-8. PubMed ID: 2525870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxazosin: a study in a cohort of patients with hypertension in general practice--an interim report.
    Langdon CG
    Am Heart J; 1991 Jan; 121(1 Pt 2):268-73. PubMed ID: 1824649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-dose and steady-state pharmacokinetics of doxazosin given in combination with chlorothiazide to hypertensive subjects.
    Conway EL; McNeil JJ; Meng L; Drummer OH; Howes LG; Raymond K; Louis WJ
    Clin Pharmacokinet; 1989 Jun; 16(6):387-91. PubMed ID: 2525447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.